Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
Q: How can potential medication errors be minimized when dispensing investigational drugs ... preparing, and labeling of study drugs; and facilitate the transition to CPOE.
today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate a clinical study of the company’s investigational UKidney ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...
The company has already kicked off an open-label Phase I trial of ABX1100 in Canada following positive results from a study of healthy volunteers.
12 天
Zacks.com on MSNHow to Play NVO Stock After New Drug's Success in Obesity StudyNovo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...
Please provide your email address to receive an email when new articles are posted on ... episodes and nighttime blood pressure (BP). The drug’s safety profile in this specific patient ...
The investigational drug, called PMD-026, is currently in phase 2 clinical trials ... “These patients have no effective medical therapies, so we hope this new drug will help fill that gap in clinical ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果